Histone Acetyltransferase Inhibitors

CBP/p300

GCN5/PCAF

TIP60

MOZ/MORF

HBO1

Histone Acetyltransferase Inhibitors, Activators, Degraders & Ligands

製品名	CBP/p300	GCN5/PCAF	TIP60	MOZ/MORF	HBO1	純度
A-485	CBP/p300					99.87%
Curcumin	CBP/p300					98.84%
C646	CBP/p300					99.88%
WM-3835					HBO1	99.78%
JZY3032	p300
SGC-CBP30	CBP/p300					99.83%
PF-9363				MOZ/MORF		99.64%
MG 149	CBP/p300		TIP60			99.60%
Butyrolactone 3		GCN5, IC₅₀: 100 μM				99.58%
Anacardic Acid	p300-HAT, IC₅₀: 8.5 μM	PCAF, IC₅₀: 5 μM				98.49%
CTB	CBP/p300					99.93%
WM-8014				MOZ/MORF		99.92%
WM-1119				MOZ/MORF		99.57%
NSC 228155	KIX-KID, IC₅₀: 0.36 μM
Garcinol		GCN5/PCAF				98.85%
GNE-049	CBP/p300					99.74%
Prifetrastat		GCN5/PCAF				99.63%
CPI-1612	CBP/p300					99.75%
PU139	CREBBP, IC₅₀: 2.49 μM p300, IC₅₀: 5.35 μM	GCN5, IC₅₀: 8.39 μM PCAF, IC₅₀: 9.74 μM				99.51%
TTK21	CBP/p300					99.39%
CPTH2		GCN5				99.82%
GSK 4027		GCN5/PCAF				98.22%
CTPB	CBP/p300					≥99.0%
NEO2734	CBP/p300					99.63%
GNE-272	CBP/p300					99.60%
TH1834			TIP60			99.79%
AUR1545		GCN5/PCAF				99.58%
I-CBP112	CBP/p300					98.43%
GNE-207	CBP, IC₅₀: 1 nM					99.94%
YF-2	CBP, EC₅₀: 2.75 μM	GCN5, EC₅₀: 49.31 μM GCN5/PCAF, EC₅₀: 29.04 μM				98.76%
Procyanidin B3	CBP/p300					99.92%
TH1834 dihydrochloride			TIP60			99.89%
JET-209	CBP, DC₅₀: 0.05 nM p300, DC₅₀: 0.2 nM					98.07%
L002	CBP/p300					99.44%
Histone Acetyltransferase Inhibitor II	CBP/p300					98.70%
GSK699		GCN5/PCAF				98.80%
GSK4028		GCN5/PCAF				98.06%
Curcumin-d₆	CBP/p300					99.78%
PCAF-IN-2		PCAF, IC₅₀: 5.31 μM				98.0%
CBP/p300-IN-3	CBP/p300					98.01%
Lys-CoA TFA	p300, IC₅₀: 50-500 nM					98.52%
YF-2 hydrochloride	CBP, EC₅₀: 2.75 μM	GCN5, EC₅₀: 49.31 μM GCN5/PCAF, EC₅₀: 29.04 μM				99.29%
TPOP146	CBP/p300					98.94%
DCH36_06	CBP/p300					99.19%
NSC 694623		PCAF, IC₅₀: 15.9 μM				99.53%
CBP/p300-IN-12	CBP/p300, IC₅₀: 166 nM					99.72%
Naphthol AS-E	KIX-KID, IC₅₀: 2.26 μM					98.0%
MOZ-IN-2				MOZ/MORF		99.58%
CBP/p300-IN-19 hydrochloride	p300-HAT, IC₅₀: 1.4 μM CBP-HAT, IC₅₀: 2.2 μM	PCAF, IC₅₀: >100 μM				99.00%
KAT6A/KAT7-IN-4				MOZ/MORF, IC₅₀: <1 nM	HBO1, IC₅₀: <1 nM	98.86%
CBP/p300-IN-10	EP300, IC₅₀: 26 nM CREBBP, IC₅₀: 39 nM					99.74%
NiCur	CBP-HAT, IC₅₀: 0.35 μM					99.11%
BT-O2C	p300
CBP/p300-IN-5	CBP/p300
B026	p300, IC₅₀: 8.1 nM CBP, IC₅₀: 9.5 nM
CBP/p300-IN-20	CBP/p300, pIC₅₀: 10.1					98.03%
CAY10669		PCAF, IC₅₀: 662 μM				99.9%
CPTH2 hydrochloride		GCN5
DS17701585	EP300, IC₅₀: 0.04 μM CBP, IC₅₀: 0.15 μM
CBP/p300-IN-14	CBP/p300
CBP/p300-IN-18	EP300, IC₅₀: .056 μM
Ep300/CREBBP-IN-4	EP300, IC₅₀: 0.024 μM CREBBP, IC₅₀: 0.064 μM
PROTAC KAT6 Degrader-1				MOZ/MORF
CBP/p300-IN-15	CBP, IC₅₀: 28 nM p300, IC₅₀: 2.5 nM
Ep300/CREBBP-IN-3	EP300, IC₅₀: 0.056 μM CREBBP, IC₅₀: 0.095 μM
P300 bromodomain-IN-1	p300, IC₅₀: 49 nM
PROTAC CBP/p300/BRD4 Degrader-1	CBP, DC₅₀: 6.55 nM p300, DC₅₀: 1.05 nM CBP, IC₅₀: 110.8 nM p300, IC₅₀: 102.6 nM
PROTAC CBP/P300 Degrader-4	CBP, DC₅₀: 10.2 nM p300, DC₅₀: 17.4 nM
CBP/p300/BRD4 ligand-1	CBP p300
ACTR-AD1 2L	CBP/p300
Ep300/CREBBP-IN-2	EP300, IC₅₀: 0.052 μM CREBBP, IC₅₀: 0.148 μM
CBP/p300-IN-17	EP300, IC₅₀: .18 μM
GSK702		PCAF
SL010110	p300
P300-IN-6	p300-HAT, IC₅₀: 7 nM
ZX079	CBP p300
PRMT/HKMT-IN-1	CBP/p300
Ep300/CREBBP-IN-8	EP300, IC₅₀: 0.014 μM CREBBP, IC₅₀: 0.018 μM
CCT077791	p300	PCAF
CBP/p300-IN-22	CBP/p300, IC₅₀: 4 nM
CBP/p300-IN-19	p300-HAT, IC₅₀: 1.4 μM CBP-HAT, IC₅₀: 2.2 μM	PCAF, IC₅₀: >100 μM
PROTAC MLT Degrader 1	p300
KAT2A/B ligand 1		GCN5/PCAF
KCN1	p300

お名前
メール *

	Sorry, but the email address you supplied was invalid.